Notes to editor
ESC Press Office
Tel: +33 (0) 7 8531 2036
Email: [email protected]
Follow us on Twitter @ESCardioNews
The hashtag for ESC Congress 2021 is #ESCCongress.
This press release accompanies both a presentation and an ESC press conference at ESC Congress 2021. It does not necessarily reflect the opinion of the European Society of Cardiology.
Funding: The ENVISAGE-TAVI AF trial was funded by Daiichi-Sankyo
Disclosures: GD’s institution has received research grants from Daiichi-Sankyo and GD has lectured about this clinical condition.
References and notes
1ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation.
2 Dangas G et al. Edoxaban vs Vitamin K Antagonists for Atrial Fibrillation After Transcatheter Aortic Valve Replacement (ENVISAGE-TAVI AF). N Engl J Med. 10.1056/NEJMoa2111016
3Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380:1695–1705.
4Holmes DR, Nishimura RA, Grover FL, et al. Annual outcomes with transcatheter valve therapy: from the STS/ACC TVT Registry. J Am Coll Cardiol. 2015;66:2813–2823.
5Tarantini G, Lefèvre T, Terkelsen CJ, et al. One-year outcomes of a European transcatheter aortic valve implantation cohort according to surgical risk: subanalysis of the SOURCE 3 Registry. Circ Cardiovasc Interv. 2019;12:e006724.
6Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376:1321–1331.
7Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380:1706–1715.
8Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609–1620.
The ESC brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people to live longer, healthier lives.
It is the world’s largest gathering of cardiovascular professionals, disseminating ground-breaking science in a new digital format. Online each day – from 27 to 30 August. Explore the scientific programme. More information is available from the ESC Press Office at [email protected].